Abstract:

Introduction: Key Populations are disproportionately affected by HIV/AIDS in all settings. Unfortunately, reaching KPs with HIV intervention is a huge challenge because of stigma, discrimination, violence, and criminalization of KPs lifestyles. Because of lack of KP specific interventions, data on KPs ART outcomes is lacking. This study determined ART outcomes among KPs 6-months after initiation.

Methodology: The study was a longitudinal study of all HIV positive KPs initiated on ART in 7 One-Stop-Shops from October 2016-March 2017. Both Time-1 and Time-2 data were abstracted from facility record after initiation and 6-month after for each patient. Data abstracted include: age, sex, marital status, educational level, employment status and ART outcome 6 months after initiation.

Results: Sixty-seven percent of patients were retained on ART, 1.8% died, 20.6% were lost to follow up, 4.5% transferred to other facilities and 6.2% stopped ART by the end of the 6^th month. PWID had highest retention rate (74.6%) more than MSM (70.2%), while FSW had the least retention rate (65.4%) but highest transfer out rate (4.9%) more than MSM (4.7%). Factors positively associated with retention at 6^th months include: Being a male P=0.007; higher education P=0.000; employed patient P=0.000; living with sex partner P=0.000.

Conclusion: This study has laid a baseline data for ART outcomes among KPs in Nigeria. Further study is however required to identify factors that could improve retention on ART among KPs. This is important if we must achieve the second and third 90s of UNAIDs 90.90.90 goals.

Keywords: HIV/AIDS, Antiretroviral therapy; Key Population in Nigeria; One-Stop-Shop; Antiretroviral therapy outcomes.

References:

[1]. Abebe Megerso,¹ Sileshi Garoma,¹ Tolosa Eticha,² Tilaye Workineh,¹ Shallo Daba,³ Mihretu Tarekegn,³ andZelalem Habtamu3 (2016); Predictors of loss to follow-up in antiretroviral treatment for adult patients in the Oromia region, Ethiopia HIV AIDS (Auckl). 2016; 8: 83–92. doi: 10.2147/HIV.S98137.

[2]. Andreas D Haas, Elizabeth Zaniewski, Nanina Anderegg, Nathan Ford, Matthew P Fox et al (2018) Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes. Journal of ineternational AIDS society February 2018 https://doi.org/10.1002/jia2.25084.

[3]. Annals of Internal Medicine (2012); Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons with HIV: Evidence-Based Recommendations from an International Association of Physicians in AIDS Care Panel. http://annals.org/aim/fullarticle/1170890.

[4]. Anthony D Harries, 1, 2 Rony Zachariah, 3 Stephen D Lawn, 2, 4 and Sydney Rosen5, 6 (2010) Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa Trop Med Int Health. 2010 Jun; 15(s1): 70–75. doi: 10.1111/j.1365-3156.2010.02506.x.

[5]. Avert (2016); Global HIV and AIDS statistics. https://www.avert.org/global-hiv-and-aids-statistics.

[6]. Avert (2016); HIV/AIDS in Nigeria; Available at https://www.AVERT.org/Professionals/HIV-around-world/Sub-Saharan-Africa/Nigeria.

[7]. Averts (2018); HIV and AIDS in Nigeria. Available at https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/nigeria.

[8]. Azadeh Khalatbari Limaki1, Behnam Farhoudi1, Mehrnaz Rasoolinejad2, Saeed Safari3 Patient Retention in Antiretroviral Therapy Programs; A Retrospective Cohort Study in a Triangular HIV Clinic. DOI: 10.22086/GMJ.V6I2.819 http://gmj.ir/index.php/gmj/article/view/819/html.

[9]. Bryan E. Shepherd, Meridith Blevins, Lara M. E. Vaz, Troy D. Moon, Aaron M. Et al (2013); Impact of Definitions of Loss to Follow-up on Estimates of Retention, Disease Progression, and Mortality: Application to an HIV Program in Mozambique. American Journal of Epidemiology, Volume 178, Issue 5, 1 September 2013, Pages 819–828, https://doi.org/10.1093/aje/kwt030.

[10].  C.M.J. Matyang, K.C. Takarinda, P.Owiti, T. Utasa-Apollo, O. Mugurungi et al (2016); Outcomes of antiretroviral therapy among younger versus older adolescents and adults in an urban clinic, Zimbabwe. Public Health Action 2016 Jun 21; 6(2):97-104. Doi: 10.5588/pha.15.0077.

[11].  CA Onoka,1 BS Uzochukwu,2 O E Onwujekwe,3 C Chukwuka,4 J Ilozumba,5 et al. (2012); Retention and loss to follow-up in antiretroviral treatment programmes in Southeast Nigeria. Pathog Glob Health. 2012 Mar; 106(1): 46–54.doi: 10.1179/2047773211Y.0000000018

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001511.

[12].  Cameron D. Factors associated with retention in HIV care at Sediba Hope Medical Centre. S Afr J HIV Med. 2015; 16 (1), Art. #347, 6 pages. http://dx.doi. org/10.4102/sajhivmed.v16i1.347.

[13].  Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, et al. (2010) Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors. PLoS ONE 5(5): e10584. https://doi.org/10.1371/journal.pone.0010584.

[14].  Dalhatu I1, Onotu D1, Odafe S1, Abiri O2, Debem H1, Agolory S3, (2016) Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012. PLoS One. 2016 Nov 9; 11(11):e0165528. doi: 10.1371/journal.pone.0165528. Collection 2016.

[15].  doi: 10.5144/0256-4947.2015.303;

[16].  Elvin H. G. Denis N. Andrew K. Yao Z. Paula B. et al (2011); Retention in Care among HIV-Infected Patients in Resource-Limited Settings: Emerging Insights and New Directions. Available at Curr HIV/AIDS Rep https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021803/.

[17].  Elvin H. Geng, David R. Bangsberg, Nicolas Musinguzi, Nneka Emenyonu, Mwebesa Bosco Bwana, et al (2010); Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach J Acquir Immune Defic Syndr. 2010 Mar; 53(3): 405–411. doi: 10.1097/QAI.0b013e3181b843f0.

[18].  Federal ministry of health, Nigeria (2014); integrated biological and behavioural surveillance survey (IBBSS) 2014. Available at https://www.google.com.ng/search?q=11.+Federal+ministry+of+health%2C+Nigeria+(2014)%3B+Integrated+biological+and+behavioural+surveillance+survey&oq=11.+Federal+ministry+of+health%2C+Nigeria+(2014)%3B+Integrated+biological+and+behavioural+surveillance+survey&aqs=chrome..69i57.1253j0j7&sourceid=chrome&ie=UTF-8.

[19].  Federal ministry of health, Nigeria (2014); National HIV sero-prevalence sentinel survey among pregnant women attending antenatal clinic in Nigeria. Available at

https://www.google.com.ng/search?q=12.+Federal+ministry+of+health%2C+Nigeria+(2014)%3B+National+HIV+sero-prevalence+sentinel+survey+among+pregnant+women+attending+antenatal+clinic+in+Nigeria&oq=12.+Federal+ministry+of+health%2C+Nigeria+(2014)%3B+National+HIV+sero-prevalence+sentinel+survey+among+pregnant+women+attending+antenatal+clinic+in+Nigeria&aqs=chrome..69i57.1456j0j7&sourceid=chrome&ie=UTF-8.

[20].  Health care worker attitudes and behaviours towards key populations in South Africa and Zambia: a cross-country analysis within the HPTN 071 (PopART) trial AIDS 2016 Conference, Durban, South Africa available at http://programme.aids2016.org/Abstract/Abstract/4352.

[21].  HIV cascade framework for key population 2015. Available at https://www.fhi360.org/sites/default/files/media/documents/linkages-hiv-cascade-framework-oct15.pdf

[22].  HIV clinical resource (2017); Benefit and risk of antiretroviral therapy. Available at https://www.hivguidelines.org/adult-hiv/antiretroviral-therapy/goals-benefits-risks/.

[23].  HIV.gov 2016, the Global HIV/AIDS Epidemic. https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics.

[24].  http://www.who.int/mediacentre/news/releases/2015/hiv-treat-all-recommendation/en/.

[25].  International AIDS Society (2014); Maximizing the benefits of antiretroviral therapy for key populations. Available at http://www.iasociety.org/WebContent/File/KAPs_WhitePaper_2014.pdf.

[26].  Janssen S, Wieten RW, Stolp S, Cremers AL, Rossatanga EG, Klipstein-Grobusch K, et al. (2015) Factors Associated with Retention to Care in an HIV Clinic in Gabon, Central Africa. PLoS ONE 10(10): e0140746. https://doi.org/10.1371/journal.pone.0140746.

[27].  Jennifer L. Weinberg and Carrie L. Kovarik, MD (2010); The WHO Clinical Staging System for HIV/AIDS, American Medical Association Journal Ethics, Volume 12, Number 3: 202-206.

[28].  Katerina AC, Moupali D, and Grant NC (2011); Linkage and Retention in HIV Care among Men Who Have Sex with Men in the United States. Available at

http://cid.oxfordjournals.org/content/52/suppl_2/S214.full.

[29].  Kudakwashe C. Takarindaab, Anthony D. Harriesbc Ray W. Shiraishid Tsitsi Mutasa-Apolloa Abu Abdul-Quaderd Owen Mugurungia (2015); Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV- infected patient cohort in Zimbabwe: 2007–2010. International Journal of Infectious Diseases. Volume 30, January 2015, Pages 98-105 https://doi.org/10.1016/j.ijid.2014.11.009.

[30].  Mazvita Naome Mberi, Lazarus Rugare Kuonza, Nomathemba Michelle Dube, Cornelius Nattey, Samuel Manda and, Robert Summers (2015); Determinant of loss to follow in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study. BMC Health Services Research201515:259. https://doi.org/10.1186/s12913-015-0912-2.

[31].  MEASURE Evaluation; Key Populations; Available at https://www.measureevaluation.org/our-work/key-populations.

[32].  Musa BM, Coker M, Bussell S, Aliyu M, Babashani M, Muhammad H et al. (2015) Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria. Ann Saudi Med 2015; 35(4): 303-311.

[33].  N MlangeniI; F SenkubugeII (2016); Antiretroviral therapy programme outcomes in Tshwane district, South Africa: A 5-year retrospective study. SAMJ, S. Afr. med. j. vol.106 n.4 Cape Town Apr. 2016 http://dx.doi.org/10.7196/samj.2016.v106i4.9375.

[34].  Nguyen DB, Do NT, Shiraishi RW, Le YN, Tran QH, Huu Nguyen H, et al. (2013) Outcomes of Antiretroviral Therapy in Vietnam: Results from a National Evaluation. PLoS ONE 8(2): e55750. https://doi.org/10.1371/journal.pone.0055750.

[35].  PAHO; Towards a Caribbean Consensus. Improving Access to Key Populations to Comprehensive HIV Health Services available at http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=23834&Itemid=270&lang=en.

[36].  Priya Lall, Sin How Lim, Norliana Khairuddin, Adeeba Kamarulzaman (2015); Review: An urgent need for research on factors impacting adherence to and retention in care among HIV‐positive youth and adolescents from key populations. Journal of international AIDS society. https://doi.org/10.7448/IAS.18.2.19393.

[37].  Rose Wilcher (2017); Call for paper: Optionizing the impact of key population programming across HIV cascade. Available at https://researchforevidence.fhi360.org/call-for-papers-optimizing-the-impact-of-key-population-programming-across-the-hiv-cascade.

[38].  S. Krishnaratne1, H. Mathema2, A. Stangl3, G. Hoddinott4, V. Bond5, J. Hargreaves1;

[39].  Seema T. Meloni, Charlotte A. Chang, Geoffrey Eisen, Toyin Jolayemi, Bolanle Banigbe, Prosper I. Okonkwo, Phyllis J. Kanki (2016) Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria. PLOS https://doi.org/10.1371/journal.pone.0164030;

[40].  Van der Kop ML, Ekström AM, Awiti-Ujiji O, Chung MH, Mahal D, et al. (2014) Factors Associated with Attrition from HIV Care during the First Year after Antiretroviral Therapy Initiation in Kenya. J AIDS Clin Res 5:354. doi:10.4172/2155-6113.1000354.

[41].  WHO (2014); Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Available at

http://apps.who.int/iris/bitstream/10665/128048/1/9789241507431_eng.pdf?ua=1&ua=

[42].  WHO (2015); Treat all people living with HIV, offer antiretrovirals as additional prevention choice for people at "substantial" risk; News release ¦ GENEVA. Available at.

[43].  WHO (2016); Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update. https://www.ncbi.nlm.nih.gov/books/NBK379696/.

[44].  Yibeltal A, Achamyeleh A, Meskele L, Lut L, Edwin W, and Wim V (2014); Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013 Globalization and Health201410:43 DOI: 10.1186/1744-8603-10-43.